Article Details

MD Anderson and AmMax Bio announce agreements to advance development of AMB-066 ...

Retrieved on: 2024-12-10 20:18:39

Tags for this article:

Click the tags to see associated articles and topics

MD Anderson and AmMax Bio announce agreements to advance development of AMB-066 .... View article details on hiswai:

Excerpt

MD Anderson and AmMax Bio announced agreements to develop and advance AmMax's AMB-066 monoclonal antibody therapy for colorectal cancer with ...

Article found on: www.mdanderson.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo